US Patent Issued to Dyne Therapeutics on Oct. 6 for "Muscle targeting complexes and formulations for treating facioscapulohumeral muscular dystrophy" (German, American Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,752,013, issued on Oct. 6, was assigned to Dyne Therapeutics Inc. (Waltham, Mass.).

"Muscle targeting complexes and formulations for treating facioscapulohumeral muscular dystrophy" was invented by Timothy Weeden (Waltham, Mass.), Nelson Hsia (Waltham, Mass.), Stefano Zanotti (Waltham, Mass.), Oxana Beskrovnaya (Waltham, Mass.), Qifeng Qiu (Waltham, Mass.), Scott Hilderbrand (Waltham, Mass.), Jochen Deckert (Bayreuth, Germany), Hans-Peter Vornlocher (Kulmbach, Germany), Markus Hossbach (Kulmbach, Germany), Kathrin Hultsch (Kulmbach, Germany), Nicholas C. Yoder (Brookline, Mass.) and Benjamin Vieira (Waltham, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Of...